Compare EMBJ & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMBJ | BAX |
|---|---|---|
| Founded | 1969 | 1931 |
| Country | Brazil | United States |
| Employees | 20744 | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 10.2B |
| IPO Year | N/A | 1994 |
| Metric | EMBJ | BAX |
|---|---|---|
| Price | $62.79 | $17.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 9 |
| Target Price | ★ $84.00 | $21.00 |
| AVG Volume (30 Days) | 1.2M | ★ 6.9M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.35% | 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | N/A | $1.96 |
| Revenue Next Year | $13.60 | $2.22 |
| P/E Ratio | $159.30 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $54.28 | $15.73 |
| 52 Week High | $80.75 | $32.68 |
| Indicator | EMBJ | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 45.70 |
| Support Level | $60.76 | $15.73 |
| Resistance Level | $65.81 | $17.50 |
| Average True Range (ATR) | 2.03 | 0.74 |
| MACD | -0.48 | -0.05 |
| Stochastic Oscillator | 18.06 | 38.58 |
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.